Two-thirds of our business is repeat business, coming from scientists we have worked with before. (2019/20)

“Thank you very much for the reliable and professional collaboration. It was a pleasure working with Gifford. Further collaboration using rat spinal chord sections are, therefore, definitely an option.” Preclinical Research Manager, German Pharma, Jan...

“If I haven’t told you before – you are all truly wonderful. Thank you sincerely for your ongoing support and collaboration.” VP of Drug Development, Australian Biotech, Nov 2019

An international customer base: 54% of our clients are from the USA, 26% from Europe, 20% from Asia/Pacific. (2019/20)